52nd week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210401663 | VIBRATION THERAPY SYSTEM AND DEVICE - A vibration therapy device that includes a housing that includes a handle portion, a head portion and a module seat defined on the head portion, an electrical source, a motor positioned in the housing, a switch for activating the motor, a push rod assembly operatively connected to the motor and configured to reciprocate in response to activation of the motor, and a therapy module removably secured to the module seat. The distal end of the push rod assembly is configured to removably receive a reciprocating attachment thereon. The therapy module at least partially surrounds the distal end of the push rod assembly. | 2021-12-30 |
20210401664 | SAFE AND EFFICIENT VIBROTACTILE MULTI-CHANNEL STIMULATION FOR THE TREATMENT OF BRAIN DISORDERS - An apparatus for treatment of a patient using vibrotactile multi-channel stimulation includes: (1) multiple vibratory stimulators; (2) multiple fastening mechanisms to secure respective ones of the vibratory stimulators to respective parts of a hand of the patient; and (3) a controller connected to the vibratory stimulators to direct operation of the vibratory stimulators. | 2021-12-30 |
20210401665 | LOW NOISE MEASUREMENT OF IMPEDANCE OF A PATIENT - A medical device for measuring an impedance of a patient or mammal when a current is applied by electrodes. The medical device includes an output transmits a drive signal to a set of drive electrodes coupled to a patient and an input receives a sense signal generated by a set of sensing electrodes coupled to the patient. A processor determines the impedance of the patient based on the drive signal transmitted to the set of drive electrodes and the sense signal received by the set of sensing electrodes. | 2021-12-30 |
20210401666 | PREVENTING INFECTIONS IN NON-STERILE AIR-CIRCULATING MEDICAL DEVICES - The present disclosure includes various examples for cooling electronics within a medical device while preventing or reducing the risk of an interior of the medical device being contaminated with a pathogen. The present disclosure includes a medical device having an air deflector to deflect potentially contaminated air from infecting a patient or caregiver. The present disclosure also includes medical devices with disinfectant devices installed to disinfect air either before entering the medical device or before exiting the device. Other examples of the present disclosure include medical devices that are sealed from outside air and fluids, and which may include a cooling device on an exterior surface which may be cleaned and/or removed after each use. | 2021-12-30 |
20210401667 | REFLEXOLOGY APPARATUS - A reflexology apparatus is described. In some examples, the reflexology apparatus can include a frame portion and one or more pressure point nodes attached to the frame portion. The reflexology apparatus can also include a removable sleeve portion that covers at least part of the frame portion and has one or more pressure point nodes attached to the removable sleeve portion. | 2021-12-30 |
20210401668 | FOOD ARRANGEMENT - A food arrangement with at least one receptacle which is filled with a liquid, sterile food; a connector, which is introduced into the receptacle and has a pierced membrane arranged in a filler neck; and a tamper-evident seal, which is connected to the connector and closes the filler neck. A sterile food arrangement is thus made available, without the need for final autoclaving of the entire filled receptacle. | 2021-12-30 |
20210401669 | INFUSION BAG OF MIDAZOLAM FOR INTRAVENOUS USE - The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof. | 2021-12-30 |
20210401670 | INTRAVENOUS FLUID CONTAINER VOLUME MONITORING SYSTEM - A system, method and device for determining a volume of a fluid in a medication container is disclosed. An infusion of a medication is initiated from a medication container. The medication container includes one or more radio frequency identification (RFID) tags affixed along a side of the container. A radio frequency (RF) signal is directed from a reader device toward the RFID tags disposed on the medication container. A signal strength of one or more returned respective RF signals from the one or more RFID tags is detected, the returned RF signals including one or more identifiers for identifying the one or more RFID tags. A threshold signal level for determining a level of fluid within the medication container is determined, and a volume of the fluid is then determined by determining which of the returned respective RF signals has a signal strength satisfying the threshold signal level. | 2021-12-30 |
20210401671 | PILL CUTTERS AND METHODS OF USE - Pill cutters and methods of cutting pills. The pill cutters may optionally include a spinnable blade and may be configured to cause the blade to spin to cut a pill. The pill cutters may be adapted to adjust the position of the pill before cutting the pill. | 2021-12-30 |
20210401672 | CHEW TOY FOR DISPENSING MEDICATION - A chew toy is provided for dispensing medication to a user, comprising: a) an outer shell comprising an opening; and b) an inner compartment comprising a channel connecting the inner compartment to the opening; wherein the inner compartment comprises means for storing the medication and dispensing the medication through the channel and out of the opening when the user chews the chew toy. In some embodiments, the inner compartment comprises a syringe or a sac. In another embodiment, the inner compartment of the chew toy may comprise a channel that connects a first opening in the chew toy to a second opening connected to an external compartment comprising an external syringe, sac, or any other means for storing and dispensing the medication. Methods of using the chew toys to dispense medication to a user are also provided. | 2021-12-30 |
20210401673 | HEALTHCARE MANAGEMENT SERVICES - Robotic pill dispensers are described. A robotic pill dispenser may include a main body forming a cavity and comprising an inlet port and an outlet port. The pill dispenser may further include a container assembly disposed in the cavity of the main body. The container assembly may include a container body and a plurality of blades fastened to the container body and dividing the container assembly into a plurality of compartments. The plurality of blades may be movable relative to the container body. The pill dispenser may further comprise a processor configured to control the pill dispenser to align a first compartment of the plurality of compartments to the outlet port, determine whether one or more medications are present in the first compartment, and control the mechanical actuator to shake at least a portion of the pill dispenser. | 2021-12-30 |
20210401674 | MEDICINE VENDING MACHINE WITH CLASSIFICATION FUNCTION - A medicine vending machine with classification function, including an electric cabinet and at least one medicine storage cabinet connected to the electric cabinet. A door of the electric cabinet is provided with a display screen, an operation area and a medicine delivery port. A medicine delivery box is provided at an interior of the electric cabinet near the medicine delivery port. A plurality of medicine cargo lanes and a medicine delivery device are provided inside the medicine storage cabinet, and a side wall of the medicine storage cabinet is provided with an isolation door. The medicine delivery device is configured to transfer the medicines stored in the medicine cargo lane to the medicine delivery box through the isolation door. | 2021-12-30 |
20210401675 | Intimate Wipes - This present invention relates to an improved sanitary wipe usable in different application to clean the hands, the face, and other areas of the body, and to provide face mask functionality. The sanitary wipes are preferably made from pre-moistened biodegradable and flushable materials designed to not adversely affect the user's skin. The sanitary wipes can be stored in different types of packages for different applications, and can be dispensed from a roll and torn away individually along a plurality of spaced apart perforations. In an alternative embodiment, the sanitary wipes can also be individually pulled from a pack and applied to the skin as needed. | 2021-12-30 |
20210401676 | ADHESIVE PATCH TO ORAL CAVITY HAVING IMPROVED STABILITY AND USABILITY - The present disclosure provides a patch which is attached to a tooth or oral mucous membrane and releases an active ingredient to a portion attached, in which the patch comprises a drug layer having an adhesive surface attached to the tooth or oral mucous membrane and a backing layer laminated on the drug layer, and comprises at least one reticular structure inside the drug layer, and is divided into at least 2 drug layers at the boundary of or by the reticular structure. | 2021-12-30 |
20210401677 | DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS - A dissolvable solid fibrous shampoo article made from a plurality of fibrous elements intertangled or otherwise associated with one another to form the fibrous article. The fibrous elements can contain a polymeric structurant, a surfactant system that is substantially free of sulfate-based surfactants, and a pH adjuster that is a monoprotic organic acid and/or a coating comprising an additive that can be a hydratrope or a diprotic and triprotic organic acid and salts thereof. | 2021-12-30 |
20210401678 | COSMETIC COMPOSITION CONTAINING INORGANIC PARTICLES FOR BLOCKING BLUE LIGHT - The present invention relates to a cosmetic composition comprising inorganic particles for blocking blue light, containing inorganic particles having a blue light blocking effect as an active ingredient in the composition, reflecting and scattering light in a blue light wavelength range, thereby significantly blocking light of a blue light area that has otherwise been difficult to block conventionally. | 2021-12-30 |
20210401679 | HAIR CONDITIONING COMPOSITION - A hair conditioner composition comprising: a) a basic amino acid; b) a fatty acid; c) a high melting point fatty alcohol; and d) an aqueous carrier; wherein a) through d) form a lamellar gel network matrix with a L | 2021-12-30 |
20210401680 | NOVEL COMPLEX AND EMULSIFIED COMPOSITION - An object of the invention is to provide a novel complex or an emulsified composition that can be used as an emulsifier. A complex formed by bonding an amide alcohol and a carboxy group-containing polymer exerts an excellent water-in-oil type or oil-in-water type emulsifying power. | 2021-12-30 |
20210401681 | OIL-IN-WATER-TYPE SKIN EXTERNAL AGENT - Provided is an oil-in-water-type skin external agent containing: (a) at least one tocopherol phosphate ester compound selected from the group consisting of tocopherol phosphate ester and a salt thereof; (b) gellan gum; (c) a dihydric or trihydric alcohol; (d) at least one oil component selected from the group consisting of esters of fatty acids having 6 to 12 carbon atoms and polyhydric alcohols, and vegetable oils; and (e) water. | 2021-12-30 |
20210401682 | TOPICAL VITAMIN C COMPOSITION - Disclosed in certain embodiments herein is a topical composition that delivers advanced environmental protection to the skin, brightens the complexion of the skin, and/or delivers anti-aging benefits to the skin by treating ntrinsic and/or extrinsic factors associated with the appearance and health of the skin. The topical composition may be an emulsion of an aqueous phase and an oily phase, or other two-phase system, that includes an ascorbate component and an antioxidant system that includes green tea polyphenols. Also disclosed herein are methods of administering the topical compositions described herein for treating a skin of a subject for effects of radical induced damage, atmospheric aging, and as part of a variety of dermatological procedures. | 2021-12-30 |
20210401683 | METHOD FOR TREATING KERATIN MATERIALS USING AN ACRYLIC ANHYDRIDE POLYMER IN OILY DISPERSION AND AN AMINE COMPOUND - The present invention relates to a process for treating keratin materials, preferably human skin, in particular the lips, preferably in at least two steps involving, in a first stage, the application to said materials of an oily dispersion (A) comprising i) particles of copolymers of alkyl acrylates and of anhydride acrylics, ii) stabilizers, iii) one or more hydrocarbon-based oils; and then, in a second stage, the application to said materials of a composition (B) comprising iv) one or more amine compounds, it being understood that the process of the invention uses v) one or more cosmetic active agents chosen from a) pigments, b) active agents for caring for the skin, and c) UV-screening agents and also d) mixtures thereof; ingredients a) to d) possibly being found in composition (A), and/or in composition (B), and/or in another composition (C). | 2021-12-30 |
20210401684 | COSMETIC COMPOSITIONS - A composition is provided. The composition is a water-in-oil emulsion comprising an aqueous phase and an oil phase. The aqueous phase comprises water, one or more humectants, one or more preservatives, one or more preservative boosters, one or more stabilizers and/or one or more pH adjusters. The oil phase comprises one or more solvents, one or more emulsifiers, one or more emollients and/or one or more aesthetic modifiers. Methods of preparing the composition and methods of improving the appearance of skin are also provided. | 2021-12-30 |
20210401685 | GRAPHENE PRODUCT AND COSMETIC USES THEREOF - A graphene product obtained from Graphene Nanofibers (GNFs), having a modified crystal structure and a defined size distribution. The product is non toxic and has useful biological properties such as modification of the adipocytes phenotype. The product can be used in cosmetics. | 2021-12-30 |
20210401686 | PHOTONIC BARRIER FOR TOPICAL USE, COMPRISING BISMUTH OXIDE COLLOIDS - The present invention relates to a topical composition creating a photonic barrier from ultraviolet radiation to visible radiation, comprising bismuth oxide colloids Bi | 2021-12-30 |
20210401687 | SUNSCREEN COMPOSITION COMPRISING SURFACE-DEFECTED CERIUM OXIDE PARTICLES, AND PREPARATION METHOD THEREFOR - Disclosed are a sunscreen composition containing surface-defected cerium oxide particles and a method for preparing the sunscreen composition. The sunscreen composition containing surface-defected cerium oxide particles has excellent ability to kill bacteria, may have a high sun protection factor (SPF) and a high PA index, and may exhibit excellent dispersion stability since the layer separation thereof does not occur even after a long period of time elapses. | 2021-12-30 |
20210401688 | ULTRAVIOLET RAY-SHIELDING AGENT COMPOSITION ABSORBING RADIATION IN UVA RANGE AND PREPARATION METHOD THEREFOR - Disclosed are a sunscreen composition that absorbs light in the UVA region and a method for preparing the sunscreen composition. Light in the UVA region is light in the wavelength band that affects skin aging and penetrates to the dermis inside the skin. Hence, when the sunscreen composition is used, the sunscreen composition absorbs the light and an effect of preventing skin aging is thus obtained. | 2021-12-30 |
20210401689 | GRAPHENE-BASED MULTIFUNCTIONAL COSMETIC COMPOSITIONS - Cosmetic compositions, including hair coloring compositions, comprising graphene oxide (GO), reduced graphene oxide (r-GO), or both, and water are provided. | 2021-12-30 |
20210401690 | Electrochemical Tooth Whitening Composition and Method Thereof - The present invention is directed to a process for electrochemically whitening a tooth, the process comprising: a) contacting the tooth with a whitening gel that is located in a dental device, the dental device comprising a positive electrode and a negative electrode; b) flowing a current between the positive electrode and the negative electrode through the whitening gel to whiten the tooth; wherein the whitening gel comprises: water; a bleaching agent; a thickener composition comprising a non-ionic compound; a surfactant; and an electrolyte source comprising a first conductive salt. | 2021-12-30 |
20210401691 | Topical Lotion having Sanitizing Properties - An alcohol-free lotion for the topical application having sanitizing properties is made by combining an aqueous phase comprising water, a water soluble preservative, an antimicrobial active, and at least one humectant with an oil phase, wherein the at least one humectant is present in the aqueous phase in the range of from 5 to 30 wt. %, wherein the oil phase comprises an oil soluble preservative, at least one surfactant, and at least one oil, wherein the surfactant is present in the oil phase in the range of from about 20 to 60 wt. %, and wherein the aqueous phase to oil phase ratio is from about 12:1 to 1:2. | 2021-12-30 |
20210401692 | Oral Care Compositions - Oral care compositions and methods for the same are provided herein. The oral care composition may include an orally acceptable vehicle, a peroxide whitening agent, and one or more gelling agents. The gelling agents may include a fatty acid. The gelling agents may be free or substantially free of fatty alcohols. The gelling agents may include at least one of palmitic acid, stearic acid, or mixtures thereof. | 2021-12-30 |
20210401693 | REDUCED HAIR DAMAGE DURING BLONDING THROUGH USE OF A BIODEGRADABLE COMPLEX FORMER - The present disclosure relates to cosmetic compositions for the oxidative treatment of keratinous fibers, in particular human hair, comprising at least one salt of a peroxo compound, at least one alkalizing agent and at least one complexing agent. Furthermore, it is an object of the present disclosure to provide a multi-component unit for the oxidative lightening of keratinous fibers, in particular human hair, comprising as first component the cosmetic agent as contemplated herein and as second component an agent comprising H | 2021-12-30 |
20210401694 | Personal Care Compositions Comprising Zinc : Usnic Acid Complexes and Methods of Use - Disclosed herein are personal care compositions comprising Zn:usnate complexes having a 1:2 zinc to usnate molar ratio. Methods of making and using the compositions are also provided. The personal care compositions may include a cleansing component and an antibacterial component, wherein the antibacterial component comprises Zn:usnate complexes having a 1:2 zinc to usnate molar ratio. | 2021-12-30 |
20210401695 | COSMETIC COMPOSITION CONTAINING BRANCHED ALKANES, SILICONES, AND NON-SILICONE FATTY COMPOUNDS - The disclosure relates to cosmetic compositions for treating, caring for, and/or conditioning keratinous substrates, the compositions comprising branched alkanes, dimethiconols, silicones other than dimethiconols and having a viscosity at 25° C. of greater than or equal to 200×10 | 2021-12-30 |
20210401696 | COSMETIC COMPOSITION HAVING STABILIZED RETINOL - A cosmetic composition, typically, including about 0.01 to about 3 wt. % of retinol; about 0.5 to about 10 wt. % of sodium polyacrylate; about 0.25 to about 10 wt. % of one or more nonionic emulsifier; about 3.5 to about 12 wt. % of a fatty phase, wherein the fatty phase comprises one or more fatty compound; and water, wherein all weight percentages are based on the total weight of the cosmetic composition. The cosmetic composition may be an oil-in-water emulsion. | 2021-12-30 |
20210401697 | COSMETIC COMPOSITIONS HAVING STABILIZED RETINOL - A cosmetic composition including about 0.01 to about 3 wt. % of retinol; about 0.01 to about 1 wt. % of tetra-di-t-butyl hydroxyhydrocinnamate; about 0.01 to about 3 wt. % of trisodium ethylenediamine disuccinate; about 0.5 to about 7 wt. % of polyglyceryl-3 methylglucose distearate; about 0.9 to about 7 wt. % of sodium polyacrylate; about 0.5 to about 8 wt. % of an oil phase; and water, where all weight percentages are based on the total weight of the cosmetic composition. Additionally, the cosmetic composition is typically formulated to form an oil-in-water emulsion. Methods for treating damaged skin with cosmetic compositions are also disclosed herein. | 2021-12-30 |
20210401698 | COSMETIC COMPOSITION HAVING RETINOL - Cosmetic compositions providing improved retinol penetration. The cosmetic compositions typically include about 0.01 to about 3 wt. % of retinol; about 0.1 to about 14 wt. % of sodium polyacrylate; about 0.2 to about 10 wt. % of one or more nonionic emulsifier; about 0.5 to about 12 wt. % of a fatty phase, wherein the fatty phase comprises one or more fatty compounds; and water, wherein the cosmetic composition is an oil-in-water emulsion, and all weight percentages are based on the total weight of the cosmetic composition. Methods for treating damaged skin with cosmetic compositions are also disclosed herein. | 2021-12-30 |
20210401699 | Oral Care Compositions and Methods for Increasing Stability of the Same - Anhydrous oral care compositions and methods for preventing phase separation in the anhydrous oral care composition are disclosed. The oral care composition may include an orally acceptable vehicle, a thickening system, and a whitening agent. The orally acceptable vehicle may include propylene glycol, and the thickening system may include a polymeric thickener. The polymeric thickener may be or include a copolymer of 2-acrylamidomethylpropanesulphonic acid or a salt thereof. | 2021-12-30 |
20210401700 | Total Body Moisture - The invention is Total Body Moisture. The Butter is used for conditioning the scalp and hair promoting hair growth and moisturizing for natural, permed, or relaxed hair as well as healing the skin all over the entire human body. It can be used for moisturizing after bath or shower, protecting skin from some UV rays, healing minor cuts, bums, and abrasions. It also can be used to soothe itching skin from the effects of eczema or psoriasis. TBM is also used to decrease wrinkles, fine lines, and minor acne on the skin surface. The main base oil of TBM is pure African Shea Butter in any shade and variation. Carrier oils such as Coconut oil, jojoba oil, black castor oil, argan oil, hemp seed oil, wheat germ oil, almond oil, avocado oil, and grapeseed oil are used to add to the clinical benefits of the pure African shea butter base. | 2021-12-30 |
20210401701 | ANTIDANDRUFF COMPOSITION - An antidandruff composition includes about 0.1 to about 1% by weight of a natural oil containing a mixture of C12 and C14 alkyl groups derived from coconut oil; about 6% by weight of a non-ionic surfactant having at least 16 carbon atoms; about 2% by weight of an antidandruff agent; about 1.5% by weight of a cationic surfactant; about 1.5% by weight of a quaternary ammonium salt; and at least 75% by weight of water. A method of making an antidandruff composition includes combining a natural oil containing a mixture of C12 and C14 alkyl groups, a non-ionic surfactant having at least 16 carbon atoms, an antidandruff agent, a cationic surfactant, a quaternary ammonium salt, and water, forming the antidandruff composition. | 2021-12-30 |
20210401702 | COSMETIC COMPOSITION PROVIDING UNIQUE SENSATIONS - A cosmetic composition providing a unique tactile sensation comprising about 0.1 to about 10 wt. % of a nonionic emulsifier; about 0.1 to about 10 wt. % of sodium polyacrylate; about 0.5 to about 15 wt. % of aluminum starch octenylsuccinate; about 0.1 to about 20 wt. % of a fatty phase that is a liquid at a temperature of 25° C. or more, the fatty phase comprising one or more fatty compounds; and water, wherein the cosmetic composition is an oil-in-water emulsion and all weight percentages are based on the total weight of the cosmetic composition. The nonionic emulsifier includes at least polyglyceryl-3 methylglucose distearate. Methods for treating damaged skin with cosmetic compositions are also disclosed. | 2021-12-30 |
20210401703 | Hair conditioning composition with antimicrobial system - A hair conditioner composition comprising: a) a fatty acid; b) a fatty alcohol; and c) an antimicrobial system comprising: i) glyceryl caprylate; and ii) one or more of 4-hydroxyacetophenone and pentylene glycol. | 2021-12-30 |
20210401704 | ORAL COMPOSITIONS - A chewable composition for teeth-whitening comprising a first region and a second region separated by a barrier layer; the first region comprising carbamide peroxide having water content of about 2% or less, a wetting agent (e.g., glycerin), an anhydrous chewing gum base having water content of about 1% or less, an anhydrous fruit acid, and one or more gum additives; and the second region comprising a chewable composition comprising a gum base, a source of bicarbonate ion, and one or more gum additives. A kit comprising separate chewable compositions corresponding to the first and second regions, and methods for whitening teeth using the chewable composition are also provided. | 2021-12-30 |
20210401705 | Oral Care Compositions - This application provides, among other things, novel aqueous oral care compositions useful for combining and delivering poorly compatible ingredients, in particular, chlorhexidine and polyphosphate salts, by formulating the composition with a surfactant. | 2021-12-30 |
20210401706 | HAIR CONDITIONING COMPOSITION FREE OF FATTY ALCOHOL - A hair conditioner composition comprising arginine, a fatty acid having a C16 to C22 alkyl chain, and an aqueous carrier, all of which form a gel structure, and wherein the composition is free of a fatty alcohol. | 2021-12-30 |
20210401707 | AZOXYSTROBIN IN A SULFATE FREE PERSONAL CARE COMPOSITION - The present invention is directed to a personal care composition comprising from about 6% to about 50% of one or more sulfate free surfactants; and from about 0.02% to about 10% of azoxystrobin. | 2021-12-30 |
20210401708 | Skin Anti-Aging Composition Containing Irilin B - The present invention relates to a skin anti-aging composition containing Irilin B (5,7,2′-trihydroxy-6-methoxyisoflavone) or a salt thereof, wherein Irilin B isolated from | 2021-12-30 |
20210401709 | PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS - The invention relates to a cosmetic process for depigmenting, lightening and/or whitening keratin materials, in particular the skin, which comprises the application of a cosmetic composition comprising a compound of formula (I): | 2021-12-30 |
20210401710 | AZOXYSTROBIN EFFICACY IN PERSONAL CARE FORMS - The present invention is directed to a personal care composition comprising azoxystrobin wherein at least about 0.05% azoxystrobin provides a deposition of greater than about 0.01 ug/cm2. | 2021-12-30 |
20210401711 | COMPOSITION FOR STABILIZING POORLY SOLUBLE INGREDIENTS AND COSMETIC COMPOSITION COMPRISING SAME - The present invention relates to a composition for stabilizing poorly soluble ingredients, comprising hydrogenated lecithin and an anionic surfactant as effective components. In addition, the present invention relates to a method for stabilizing poorly soluble ingredients in cosmetic formulations by using said composition for stabilizing poorly soluble ingredients, a cosmetic composition comprising said composition for stabilizing poorly soluble ingredients and a poorly soluble component, and a preparation method of said cosmetic composition. The composition for stabilizing poorly soluble ingredients of the present invention stabilizes the poorly soluble ingredients in cosmetic formulations, thereby preventing same from being separated or precipitated. Accordingly, by overcoming the limitations of poorly soluble ingredients that tend to precipitate over time and thus were difficult to apply to cosmetic compositions, the present invention provides a cosmetic composition containing such poorly soluble ingredients and having various types of formulations. | 2021-12-30 |
20210401712 | METHOD FOR TREATING HAIR, COMPRISING THE APPLICATION OF AN ORGANIC SILICON COMPOUND, AN ALKALISING AGENT AND A FILM-FORMING POLYMER - It is an object of the present disclosure to provide a method for treating keratinous material, in particular human hair, comprising the following steps:
| 2021-12-30 |
20210401713 | METHOD FOR COATING KERATIN FIBERS - A film coating for keratin fibers is described. The film coating is produced by applying to the keratin fibers a pretreatment composition and a film forming composition and curing the compositions to produce the film coating. The coating may be clear and function as a styling, conditioning and holding. The coating alternatively may contain pigment particles and provide a color coating. | 2021-12-30 |
20210401714 | Composition For Enhancing Protein Strength - A composition for enhancing protein strength according to the present invention contains an aminosilane compound capable of covalent binding with a protein of hair, scalp, skin, nails, leather, or textile, so that the protein and the amino silane compound form a covalent bond, and thus the composition can improve the protein strength enhancement effect and maximize the semi-permanent protein strength enhancement effect. | 2021-12-30 |
20210401715 | COSMETIC COMPOSITION FOR IMPROVED PENETRATION - A cosmetic composition for improved penetration of skin active agents including about 0.1 to about 10 wt. % of C-glycoside; about 0.1 to about 5 wt. % of polyglyceryl-3 methylglucose distearate; about 0.1 to about 5 wt. % of sodium polyacrylate; and water, wherein the cosmetic composition is an oil-in-water emulsion, and all weight percentages are based on the total weight of the cosmetic composition. Methods for treating damaged skin with cosmetic compositions are also disclosed. | 2021-12-30 |
20210401716 | NATURAL NON-SULFATE RINSE-OFF CLEANSING COMPOSITIONS WITH HIGH OIL LOADING, AND METHODS OF USE - The present disclosure relates to natural non-sulfate rinse-off rinse-off cleansing compositions with high oil load, methods of use and making. The cleansing compositions include: (a) up to 20 wt. % of one or more anionic surfactants selected from acyl taurates, acyl glutamates, acyl isethionates, salts thereof, and mixtures thereof; (b) one or more nonionic surfactants comprising alkyl polyglucosides; (c) one or more amphoteric surfactants; (d) one or more oil-based conditioning agents selected from squalane, glyceryl esters, natural oils, esters other than glyceryl esters, and mixtures thereof; and (e) one or more thickening agents. The cleansing compositions are particularly useful for cleansing hair. | 2021-12-30 |
20210401717 | COMPOSITIONS AND METHODS FOR DENTAL CARE - Disclosed herein are compositions and methods for their use in treating dental disorders, whitening teeth, restoring and retaining the tooth structure and restoring the mineral content of the tooth-mineral loss due to demineralization, wherein the compositions include a first formulation that includes a polypeptide effective to treat a dental disorder and/or whiten teeth, and one or more further formulations including at least one calcium ion source and/or at least one phosphate ion source, wherein the first formulation is configured to release the polypeptide more rapidly than Ca | 2021-12-30 |
20210401718 | PEPTIDE FOR PROMOTING MUCOUS MEMBRANE PERMEATION AND COMPOSITION CONTAINING SAME - A peptide and a peptide multimer according to the present invention serve to control tight bonding between cells, and thereby facilitate the absorption, through a mucous membrane, of an active ingredient of co-administered drugs and the like. Thus, the bioavailability of the active ingredient can be significantly improved, and as a result, the therapeutic effect of the active ingredient can be significantly improved. | 2021-12-30 |
20210401719 | HAIR STYLING COMPOSITIONS FOR IMPROVING THE ELONGATION OF HAIR CURLS - Hair styling compositions including about 5 wt. % or more of hydrogenated starch hydrolysate; about 3 wt. % or more of polyol, wherein a weight ratio of the total amount of hydrogenated starch hydrolysate to the total amount of polyol is from 1:1 to 10:1; about 1 to about 10 wt. % of a plant or vegetable based oil, wherein the plant or vegetable based oil comprise shea butter, castor oil, or a combination thereof; about 0.1 to about 7 wt. % of a cationic surfactant; about 0.5 to about 10 wt. % of emulsifiers are chosen from a glyceryl ester, a fatty alcohol, and a combination thereof; and water, wherein all weight percentages are based on the total weight of the hair styling composition. Methods for styling hair using the hair styling compositions are also disclosed herein. | 2021-12-30 |
20210401720 | Methods of Increasing the Volume of a Fiber, Such as Mammalian Hair, and/or Altering the Structure of a Fiber with a Chitosan Polyelectrolyte Complex - The invention includes methods of increasing the volume of a fiber by applying to the fiber a chitosan cross linked with or complexed to an aldehyde-bearing compound, and a polyanion. The fiber is then dried forming a chitosan polyelectrolyte complex on the hair that increases the dimension of the fiber. The fiber may be wet prior to application and may be a mammalian hair. Also included are method of semi-permanently altering the structure of hair that includes topically applying to hair a chitosan cross linked with or complexed to an aldehyde-bearing compound, and a polyanion. Also contemplated within the scope of the invention is a hair care polyelectrolyte complex that includes a chitosan cross linked with or complexed to an aldehyde-bearing compound, and a polyanion. Systems for hair treatment are also encompassed within the scope of the invention and include at least two formulations: a first formulation comprising a chitosan cross linked with or complexed to an aldehyde-bearing compound, and a second formulation comprising a polyanion. Such systems may be included in hair care kits. | 2021-12-30 |
20210401721 | OIL-IN-WATER TYPE DERMATOLOGICAL COMPOSITION FOR EXTERNAL USE - An oil-in-water emulsion composition for skin includes 0.2 to 2.5% by mass of polyisobutene having a relative mass in a range of 30,000 to 100,000. The composition is applied to skin except for a lip. | 2021-12-30 |
20210401722 | COSMETIC COMPOSITIONS COMPRISING BIODEGRADABLE POLYMERS - Disclosed is a cosmetic composition that contains at least one polyhydroxyalkanoate (PHA) in the form of particles having an average diameter (d50) from 0.1 nm to 50 μm. The PHA may comprise between 0.1% w/w and 30% w/w of the total cosmetic composition, and some embodiments may utilize between 1% w/w and 8% w/w. The composition may include a silicone external phase or may be in the form of a loose or packed powder. Various PHAs may be utilized, although advantageously, the PHA may have a chain length 1 and 8 carbons. In some embodiments, the PHA may be selected to have an oil absorption of between 60 to 150 grams of a desired oil per 100 grams of PHA, where the desired oil may be, e.g., sebum. Further, the composition may optionally include one or more pigments. In use, the composition may be applied to a user's skin or hair. | 2021-12-30 |
20210401723 | COSMETIC COMPOSITIONS CAPABLE OF FORMING A MULTILAYER STRUCTURE AFTER APPLICATION TO A KERATINOUS MATERIAL CONTAINING A COMBINATION OF SILICONE RESINS - Cosmetic compositions capable of forming a multilayer structure after application to a keratinous material containing a combination of silicone resins are provided, as well as methods of applying such compositions to a keratinous material. | 2021-12-30 |
20210401724 | WATER-IN-OIL EMULSIONS CONTAINING LOW HLB SURFACTANT, SILICONE GUM AND SILOXYSILICATE RESIN - The invention relates to water-in-oil (w/o) emulsion compositions for hair, eyelashes and/or eyebrows including at least one low HLB surfactant, at least one silicone gum, and at least one siloxysilicate resin, as well as to methods of making and using such emulsions. Preferably, the composition is a composition for eyelashes, for example a mascara composition further including at least one colorant. | 2021-12-30 |
20210401725 | POLYMER BLEND - A polymer blend is provided comprising: (A) multistage polymer, comprising: acrylate rich stage comprising: structural units of monoethylenically unsaturated non-ionic, acrylate rich stage monomer selected from C | 2021-12-30 |
20210401726 | Smuthcentz - The claimed invention is lotion candle/melt. There is no wax in the product. They are safe if consumed by pets or children. They ae also safe for the environment being as they are not made from a kerosine by product. They are also safe to apply on your skin as a moisturizer due to the fact that they do not contain any wax product that is produced from kerosene. Child and pet safe they can be consumed with out harmful side effects being that they're made of all natural material if you are not allergic They contain no petroleum byproducts. | 2021-12-30 |
20210401727 | AEROSOLIZED COMPOSITIONS, SYSTEMS, KITS, AND METHODS FOR KERATINOUS SUBSTRATES - The disclosure relates to compositions for treating, caring for, and/or conditioning keratinous substrates, the compositions comprising (a) at least one vegetable oil; (b) at least one fatty alcohol; (c) at least one cationic conditioning agent; and (d) at least one propellant, as well as systems and kits comprising the compositions, and methods of using the compositions. | 2021-12-30 |
20210401728 | Topical Compositions and Methods to Promote Optimal Dermal White Adipose Tissue Composition in Vivo - Topical compositions and methods are provided that are effective for promoting an optimal composition of dermal white adipose tissue in vivo comprising an adipogenic agent, a retarder of lipogenesis or lipolytic agent and at least one penetrant. | 2021-12-30 |
20210401729 | COLLECTIVE LOTION AND SCENT REMOVER - A kit for comfortably collecting the scent of one person prolonging it and applying that scent elsewhere on the person or on another person is disclosed. In certain embodiments, the scent collected is the scent from an individual. In still other preferred embodiments, the scent collected is from a sexual partner and is applied elsewhere on that person's body or clothing or to the person's sexual partner. The scent can be collected by applying a collective lotion, which may be provided on a moistened pad, to a user's finger, an applicator or the like and touching or rubbing the desired region. Thereafter, the user's finger or the applicator can be used to apply the scent where desired, such as on their hair, shoulder, arm, chest, external skin area above the upper lip and underneath the nose, hand, wrist, neck, or the like, or on those areas of another desired person. A scent removed may also be provided to subsequently remove the scent transferred as desired. | 2021-12-30 |
20210401730 | USE OF EXTRACTS OF AGAVE FOR A HAIR APPLICATION - The invention relates to the non-therapeutic cosmetic use of an extract of | 2021-12-30 |
20210401731 | Anti-Aging Formula - An anti-aging formula is provided. The anti-aging formula comprises a first microbial blend, a second microbial blend, chondroitin sulfate, vitamin D | 2021-12-30 |
20210401732 | COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS - The disclosure relates to a method for treating a viral pulmonary infection (e.g., COVID-19 infection), the method comprising the step of delivering a composition comprising at least one bronchodilator or a pharmaceutically acceptable salt thereof and at least one pulmonary surfactant or a pharmaceutically acceptable salt thereof to the airway of a subject in need of treatment for the pulmonary viral infection. | 2021-12-30 |
20210401733 | SKIN CR ME - A skin crème with CBD variants. The skin crème is a formulation to relieve joint and muscle pain, pain from arthritis. The skin crème also works to repair skin and reduce wrinkles, as the CBD nourishes the skin and has been shown to be more effective in skin repair and wrinkles reduction. There are three embodiments that include different forms of CBD. The first embodiment is a skin crème with CBD oil. The second embodiment is a skin crème with water soluble CBD. The third embodiment is a skin crème with Nano CBD. | 2021-12-30 |
20210401734 | TRANSDERMALLY ABSORBABLE BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND - A transdermally absorbable base material including: a lipid peptide compound including at least one of compound of Formula (1) below and the similar compounds or pharmaceutically usable salts thereof; a surfactant; a specific polyhydric alcohol; a fatty acid; and water, | 2021-12-30 |
20210401735 | DRUG DELIVERY DEVICE - Embodiments of the invention include devices, compositions and methods for the controlled release of therapeutic substances, such as drugs. Control over the rate of release of the therapeutic substances from the devices is achieved by the use of nanoporous membranes in which the pore size is matched to the molecular diameter of the therapeutic substances. Some embodiments of the invention achieve zero-order release by the use of membranes with a pore diameter that is more than five times the Stokes' diameter of the therapeutic substance released. | 2021-12-30 |
20210401736 | SEMI-SOLID CHEWABLE GEL CANNABINOID COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF - A semi-solid chewable gel composition, comprising a gelling component in a sufficient amount to provide a cohesive gelled product, a cannabinoid component comprising cannabidiol, and a complexing component, wherein the complexing component is configured to reduce the bitterness of the cannabinoid component by complexing with the cannabinoid component. | 2021-12-30 |
20210401737 | PREBIOTIC AND PROBIOTIC COOKIE PREPARATION - A cookie that provides a prebiotic effect and/or a probiotic effect to a consumer is described. The cookie fails to contain refined sugars, synthetic vitamins, genetically modified organisms (GMOs), artificial sweeteners, and artificial preservatives. The cookie comprises at least two baked food compositions formed into a biscuit. Each of the at least two baked food compositions contains a polyphenol, a resistant starch, and a prebiotic soluble fiber. A crème filing is sandwiched between the at least two baked food compositions. The crème filing comprises a resistant starch, a nut butter, a vegetable fat, and spores of a probiotic bacterium. Consumption of the cookie increases | 2021-12-30 |
20210401738 | DIETARY SUPPLEMENT COMPOSITIONS - A cannabinoid (CBD) and methylsulfonylmethane (MSM) formulation for ameliorating the symptoms of one or more of Autoimmune diseases, muscle and joint inflammation and pain, and psychological disorders such as; anxiety, fear, and panic in canines, The method of administration is an oral chewable supplement. Other ingredients within the chewable will help with internal dissemination of the CBD and MSM, and give added nutrients to the canine in a pleasant formulation. | 2021-12-30 |
20210401739 | SOFT CHEWABLE DOSAGE FORM - The invention relates to a soft chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the soft chewable dosage form and wherein the soft chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the soft chewable dosage form. | 2021-12-30 |
20210401740 | METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC COPD WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS - A method is provided for improving lung function in COPD by administering a muscarinic antagonist with a high efficiency nebulizer. | 2021-12-30 |
20210401741 | Intravesical Device for Controlled Drug Delivery - Implantable devices and methods for delivery of lidocaine or other drugs to a patient are provided. In one embodiment, the device includes a first drug portion which has a first drug housing which contains a first drug formulation in a solid form which includes a pharmaceutically acceptable salt of lidocaine; and a second drug portion which includes a second drug housing which contains a second drug formulation which includes lidocaine base. In another embodiment, the device includes a drug reservoir component which has an elastic tube having at least one lumen bounded by a porous sidewall having an open-cell structure, a closed-cell structure, or a combination thereof; and a drug formulation contained within the at least one lumen, wherein the device is deformable between a low-profile deployment shape and a relatively expanded retention shape. | 2021-12-30 |
20210401742 | Methotrexate Composition - A Methotrexate composition for oral administration is provided comprising a pharmaceutically acceptable salt of Methotrexate and an aqueous carrier agent. The Methotrexate salt is substantially or completely soluble in the aqueous carrier agent, forming an aqueous solution. There is also provided a method of manufacturing a Methotrexate composition for oral administration, comprising mixing a pharmaceutically acceptable salt of Methotrexate with an aqueous carrier agent until the Methotrexate salt is substantially or completely soluble in the carrier agent to form an aqueous solution. | 2021-12-30 |
20210401743 | Leucine/Peptide Composition and Method of Formulation - Disclosed is a method for providing amino acids in a form having improved solubility and/or improved suspension properties, and a product made by the method. The method also provides protein and amino acid compositions having decreased viscosity following heat treatment. | 2021-12-30 |
20210401744 | PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS - The present disclosure is broadly concerned with petrolatum-based compositions as a suspension matrix for the active ingredients. The disclosure is also concerned with processes for forming stable emulsions of active ingredients in petrolatum. | 2021-12-30 |
20210401745 | EMULSION FORMULATION AND METHOD FOR PREPARING THE SAME - This invention provides a water-in-oil (w/o) emulsion formulation that stably contains 3 types of peptides having 4 linked CTL epitopes. This invention also provides a method for efficiently preparing the w/o emulsion formulation containing 3 types of peptides having 4 linked CTL epitopes. This invention provides a w/o emulsion formulation that stably contains 3 types of peptides having 4 linked CTL epitopes and a method for efficiently preparing such w/o emulsion formulation. In addition, this invention provides an improved method and an apparatus to prepare such emulsion formulation. | 2021-12-30 |
20210401746 | STABLE CANNABINOID COMPOSITIONS - The present application discloses powder and aqueous formulations. These include but are not limited to water dispersible cannabinoid formulations, especially those comprising cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN) as well as other cannabinoids. Generally, these embodiments do not include major amounts of Tetrahydrocannabinol (THC), but certain embodiments are envisioned that do contain measurable concentrations of THC. Embodiments may include one or more emulsifiers selected from the group consisting of Tween (polysorbate) 20, Tween 60, Tween 80, Span 20, Span 60, Span 80, Poloxamer 188, Vit E-TPGS (TPGS), TPGS-1000, TPGS-750-M, Solutol HS 15, PEG-40 hydrogenated castor oil, PEG-35 Castor oil, PEG-8-glyceryl capylate/caprate, PEG-32-glyceryl laurate, PEG-32-glyceryl palmitostearate, Polysorbate 85, polyglyceryl-6-dioleate, sorbitan monooleate, Capmul MCM, Maisine 35-1, glyceryl monooleate, glyceryl monolinoleate, PEG-6-glyceryl oleate, PEG-6-glyceryl linoleate, oleic acid, linoleic acid, propylene glycol monocaprylate, propylene glycol monolaurate, polyglyceryl-3 dioleate, polyglyceryl-3 diisostearate and lecithin. | 2021-12-30 |
20210401747 | NANOPARTICLES CARRYING ANTIBIOTICS - The subject invention pertains to polyacrylate homopolymers produced from acrylolated drug monomers. The homopolymers can be produced in the form of nanoparticles. The nanoparticles comprising the homopolymers can be produced via a free radical-induced emulsion polymerization of the acrylolated drug monomers to produce an aqueous emulsion of uniformly sized nanoparticles. The homopolymers of the invention containing acrylolated antibiotic monomers can be active against Gram-positive and Gram-negative bacteria, such as | 2021-12-30 |
20210401748 | Powder for oral suspension containing lamotrigine - This document discloses a powder formulation of lamotrigine for oral administration. Also disclosed is a suspension of lamotrigine and a method of treating diseases. | 2021-12-30 |
20210401749 | POLYMER PARTICLES - Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents. | 2021-12-30 |
20210401750 | NOVEL NANOPARTICLES AND NANONETWORKS FORMED THEREFROM - Nanoparticles and nanonetworks formed of these nanoparticles are provided. Methods for forming such nanoparticles and nanonetworks are also provided, as well as uses of the nanoparticles and/or nanonetworks, including their use for drug delivery. | 2021-12-30 |
20210401751 | COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND METHODS FOR SAME - Compositions containing a protease inhibitor for treating viral infections and methods for treating a patient before, during, or after exposure to an infectious agent by administering such compositions are described herein. | 2021-12-30 |
20210401752 | PEDIATRIC DOSAGE FORMS, METHODS OF MAKING AND USING - Pediatric and modified release dosage forms of vitamin D compounds, and methods of making and using the same, are disclosed. | 2021-12-30 |
20210401753 | Method for improving the dissolution profile of a biologically active material - A method for improving the dissolution profile of a biologically active material | 2021-12-30 |
20210401754 | LAXATIVE TABLET - Provided is a laxative tablet which includes magnesium oxide as a main constituent, wherein (1) the particle size by volume of 50% (D50) of particles which emerge when the tablet is suspended in water is 70 μm or less as determined by laser diffractometry, (2) the particle size by volume of 90% (D90) of the particles which emerge when the tablet is suspended in water is 130 μm or less as determined by laser diffractometry, and (3) the dissolution time of the tablet when the tablet is suspended in water according to the Japanese Pharmacopoeia—general testing methods—dissolution testing methods is 10 seconds or less. | 2021-12-30 |
20210401755 | SOLID FORMULATION - A solid dosage form for injection and a method of making said dosage form wherein the dosage form has a moisture content of 5% (w/w) or less. The solid dosage form comprises a dried matrix including a first excipient and 0.01 to 50 (w/w) or more than 50% and up to 80% (w/w) of a therapeutic peptide; and one or more additional excipients and at least 5% (w/w) of CMC, based on the total weight of the solid dosage form, wherein the dosage form has a width of 0.5 mm to 2 mm. | 2021-12-30 |
20210401756 | TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS - The present document describes a monolithic tablet dosage form for delivery of an active ingredient at two different release rates comprising a carboxyl polymer complexed with a multivalent cation and a disintegrating agent for a first initial fast release of the active ingredient, and a modulating agent for a second sustained release of the active ingredient. Also described are processes for preparing the carboxyl polymer complexed with a multivalent cation, and carboxyl polymer made from the process. | 2021-12-30 |
20210401757 | SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH OLANZAPINE AND METFORMIN - Sublingual delivery vehicles (SDVs) including tablets and gel strips may mitigate or eliminate side effects associated with active ingredients included in the SDVs. An exemplary SDV may include: an ingredient mixture including a flavoring agent and a lubricant; a specified dose of olanzapine; and a specified dose of metformin, wherein the SDV dissolves within thirty seconds of sublingual administration. A method of manufacturing an SDV may include mixing a set of ingredients, wherein the set of ingredients includes: a flavoring agent, a lubricant, a specified dose of olanzapine, and a specified dose of metformin; and forming the SDV from the mixed set of ingredients. A method for treating mental disorders may include administering, twice per day, an ingredient mixture including: a flavoring agent; a lubricant; a specified dose of olanzapine; and a specified dose of metformin, wherein the ingredient mixture is administered via a sublingual delivery vehicle (SDV). | 2021-12-30 |
20210401758 | SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH TRAZODONE - Sublingual delivery vehicles (SDVs) including tablets and gel strips may mitigate or eliminate side effects associated with active ingredients included in the SDVs. An exemplary SDV may include: an ingredient mixture including a flavoring agent and a lubricant; and a specified dose of trazodone, wherein the SDV dissolves within thirty seconds of sublingual administration. A method of manufacturing an SDV may include mixing a set of ingredients, wherein the set of ingredients includes: a flavoring agent, a lubricant, and a specified dose of trazodone; and forming the SDV from the mixed set of ingredients. A method for treating mental disorders may include administering, once a day, an ingredient mixture including: a flavoring agent; a lubricant; and a specified dose of trazodone, wherein the ingredient mixture is administered via a sublingual delivery vehicle (SDV). | 2021-12-30 |
20210401759 | PHARMACEUTICAL FORMULATIONS - The present invention provides compositions and methods for the treatment or prevention of pulmonary hypertension comprising administering an ascomycin, or a pharmaceutically acceptable salt, solvate, analog, or prodrug thereof to the patient with pulmonary hypertension. Described herein are liquid formulations which deliver an ascomycin. The liquid formulation can be placed in a soft gelatin capsule. | 2021-12-30 |
20210401760 | Composite Coating for an Active Agent - Active agent encapsulated with a protective composite coating is provided. The coating comprises a first hydrophilic water-swellable inner coating comprising a sealant agent combined with a plasticizer to coat particles of the active agent; and a second hydrophobic outer coating comprising a hydrophobic component combined with an enteric polymer and a plasticizer. The composite coating enhances the stability/viability of the active agent during prolonged storage prior to administration, and on exposure to harsh physiological conditions (e.g. gastric environment) following administration to permit enteric delivery of the active agent. A method of preparing the coated active agent is also provided. | 2021-12-30 |
20210401761 | WATER-SOLUBLE LUTEIN ESTER MICROCAPSULES AND A METHOD OF PREPARING THE SAME - A method of preparing water-soluble lutein ester microcapsules includes: mixing marigold flower particles with an extracting solvent, refluxing at 65-85° C.; removing the extracting solvent to obtain a crude extract; washing the crude extract with a washing solvent; removing the washing solvent to obtain a crude lutein ester; adding an oil-phase antioxidant and a vegetable oil to the crude lutein ester, mixing and heating at 90-100° C. to obtain a lutein ester oil phase; adding a wall material, an emulsifier, a water-phase antioxidant, and a water-phase filler into water, and heating to obtain a water phase; adding the lutein ester oil phase to the water phase under a high-speed shearing, mixing evenly, and homogenizing to obtain a lutein ester emulsion; drying twice to obtain semi-finished lutein ester microcapsules; and solidifying to obtain the lutein ester microcapsules. Water-soluble lutein ester microcapsules prepared by the method are also disclosed. | 2021-12-30 |
20210401762 | COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS - The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid. | 2021-12-30 |